Retrophin (RTRX) PT Raised to $33 at BMO Capital Nov 6, 2020 07:23AM
Retrophin (RTRX) PT Lowered to $33 at BMO Capital Aug 23, 2019 06:54AM
Retrophin (RTRX) PT Lowered to $38 at BMO Capital Aug 22, 2019 07:01AM
Retrophin (RTRX): Positive Catalyst Sparks PT Cut - BMO Apr 4, 2018 08:26AM
Retrophin (RTRX): Sparsentan Phase III Gets the Green Light - BMO Feb 28, 2018 07:13AM


Mar 2, 2017 05:52AM Retrophin (RTRX) PT Lowered to $45 at BMO Capital on Phase 3 Trial Initiation for Sparsentan; '75% Probability of Success'
Dec 14, 2016 12:58PM Retrophin (RTRX) Bullish View Reiterated at BMO Following Conference Presentation
Nov 30, 2016 04:30PM Retrophin to Present at the BMO Capital Markets Healthcare Conference
Nov 21, 2016 09:35AM Retrophin (RTRX) PT Raised to $46 at BMO as Details Strengthen DUET Data
Nov 11, 2016 08:37AM Retrophin (RTRX) Bullish Stance Reiterated at BMO as RE-024 Gets Accelerated Path To Market
Nov 9, 2016 01:10PM Today's Biotech Upside Could Be Just the Start - BMO Capital (IBB) (XBI)
Nov 4, 2016 07:29AM Retrophin (RTRX): DUET Data At ASN Could Preview FDA - BMO
Sep 7, 2016 04:14PM Retrophin (RTRX) PT Raised to $40 at BMO Capital
Aug 5, 2016 09:23AM Retrophin (RTRX) Setup Into DUET Data Remains Favorable - BMO
Apr 11, 2016 04:28PM BMO Capital Starts Retrophin (RTRX) at Outperform